Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin-Rong Yang

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Oncotargets and Therapy|November 29, 2017
The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysisXu-Xiao Chen, Jian-Wen Cheng, Ao Huang, et al.
Journal of Cancer|October 5, 2016
Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral HeterogeneityAo Huang, Xin Zhang, Shao-Lai Zhou, et al.
Oncotargets and Therapy|October 30, 2016
Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestationZi-Jun Gong, Wei Guo, Yun-Fan Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2009
A comparison of hepatic mucinous cystic neoplasms with biliary intraductal papillary neoplasmsTao Li, Yuan Ji, Xu-Ting Zhi, et al.
Genes & Diseases|March 18, 2020
Corrigendum to "A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance" [Genes Dis 694 (2019) 419-430]Wei Wang, Bo Hu, Jiang-Jiang Qin, et al.
Genes & Diseases|December 14, 2019
A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistanceWei Wang, Bo Hu, Jiang-Jiang Qin, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Limited bias effect of intratumoral heterogeneity on genetic profiling of hepatocellular carcinomaAo Huang, Yu-Peng Wang, Jian Wang, et al.
Current Stem Cell Research & Therapy|April 1, 2024
Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and ImmunityQian Dai, Jie Zhu, Jing Yang, et al.
Clinical Chemistry and Laboratory Medicine|March 25, 2016
Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resectionBei-Li Wang, Lu Tian, Xing-Hui Gao, et al.
Journal of Pain Research|August 14, 2024
Study on the Efficacy and Safety of the Huangqi Guizhi Wuwu Decoction in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Meta-Analysis of 32 Randomized Controlled TrialsXin-Rong Yang, Xin-Yi Zhang, Yi-Jia Xia, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Oncotargets and Therapy|November 29, 2017
The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysisXu-Xiao Chen, Jian-Wen Cheng, Ao Huang, et al.
Journal of Cancer|October 5, 2016
Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral HeterogeneityAo Huang, Xin Zhang, Shao-Lai Zhou, et al.
Oncotargets and Therapy|October 30, 2016
Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestationZi-Jun Gong, Wei Guo, Yun-Fan Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2009
A comparison of hepatic mucinous cystic neoplasms with biliary intraductal papillary neoplasmsTao Li, Yuan Ji, Xu-Ting Zhi, et al.
Genes & Diseases|March 18, 2020
Corrigendum to "A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance" [Genes Dis 694 (2019) 419-430]Wei Wang, Bo Hu, Jiang-Jiang Qin, et al.
Genes & Diseases|December 14, 2019
A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistanceWei Wang, Bo Hu, Jiang-Jiang Qin, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Limited bias effect of intratumoral heterogeneity on genetic profiling of hepatocellular carcinomaAo Huang, Yu-Peng Wang, Jian Wang, et al.
Current Stem Cell Research & Therapy|April 1, 2024
Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and ImmunityQian Dai, Jie Zhu, Jing Yang, et al.
Clinical Chemistry and Laboratory Medicine|March 25, 2016
Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resectionBei-Li Wang, Lu Tian, Xing-Hui Gao, et al.
Journal of Pain Research|August 14, 2024
Study on the Efficacy and Safety of the Huangqi Guizhi Wuwu Decoction in the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: Meta-Analysis of 32 Randomized Controlled TrialsXin-Rong Yang, Xin-Yi Zhang, Yi-Jia Xia, et al.
Pageof 12